Fanatrex
Product Images NDC 43093-105

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Fanatrex (NDC 43093-105). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by California Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fanatrex Box (1 Fanatrex Carton)

Fanatrex Box (1 Fanatrex Carton)
This is a description of FANATREX™ oral suspension with a dosage of 25 me/mL. It should be stored at room temperature. The manufacturer is Fusion Pharmaceuticals LLC. The text mentions the NDC code 4309310501, and there is unreadable text mixed in with English, likely due to errors.*
FDA Label Image

Gabapentin Label (2 Gabapentin Label)

Gabapentin Label (2 Gabapentin Label)
This is a label for Gabapentin medication repackaged by Fusion Pharmaceuticals, LLC. The medication contains 1-{aminomethyl)cyclohexaneacetic acid and the CAS number is 60142-96-3. The label contains cautionary information, stating not to use the medication if the safety seal is broken. The net content is 105 3 =FUST. The label is intended for manufacturing, processing, repacking, or prescription compounding purposes.*
FDA Label Image

Suspension Label (3 Suspension Label)

Suspension Label (3 Suspension Label)
This is an Oral Suspension Vehicle for Prescription Compounding use only. It is dye and paraben-free. The ingredients include water, banana and marshmallow flavors, glucosamine, and other elements. The product is not recommended for use if the safety seal is broken. It is manufactured by Fusion Pharmaceuticals LLC in California, USA.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.